Scancell Holdings to Acquire Neuphoria Therapeutics for $25 Million
Scancell Holdings plc (SCNLF) entered a merger agreement on July 23, 2026, to acquire Neuphoria Therapeutics Inc. (NEUP) in a deal valued at $25 million. Deal Structure: Each…
Written byAsif SuriaSource: InsideArbitrage
Scancell Holdings plc (SCNLF) entered a merger agreement on July 23, 2026, to acquire Neuphoria Therapeutics Inc. (NEUP) in a deal valued at $25 million. Deal Structure: Each outstanding share of Neuphoria common stock will be converted into 37.77199 Scancell American Depositary Shares (ADSs) and one Contingent Value Right (CVR). The CVR gives shareholders the